<HTML>
<HEAD>
   <TITLE>c47561_s8.htm -- Converted by SEC Publisher, created by BCL Technologies Inc., for SEC Filing</TITLE>
</HEAD>

<BODY bgcolor="#ffffff">




<P align="center">
<B><FONT size=4 face="serif">SECURITIES AND EXCHANGE COMMISSION </FONT></B><B><FONT face="serif"><br>
Washington, D.C. 20549</FONT></B><FONT face="serif"> </FONT></P>
<P align="center">
<B><FONT size=5 face="serif">FORM S-8</FONT></B><FONT size=5 face="serif"> </FONT></P>
<P align="center">
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><FONT face="serif">Registration Statement</FONT></B><FONT face="serif"> </FONT><B><FONT face="serif"><br>
Under</FONT></B><FONT face="serif"> </FONT><B><FONT face="serif"><br>
The Securities Act of 1933, as
amended.</FONT></B><FONT size=2 face="serif"> </FONT></P>
<P align="center">
<B><FONT size=6 face="serif">VISUALMED CLINICAL SOLUTIONS CORP.<br>
</FONT></B><FONT size=2 face="serif">(Exact
name of registrant as specified in charter.)</FONT></P>
<P align="left">&nbsp;</P>
<table width="100%"  border="0" cellspacing="0" cellpadding="0">
  <tr valign="top">
    <td width="45%"><center>
      <B><FONT size=2 face="serif">Nevada</FONT></B>
    </center></td>
    <td width="8%"><center>
    </center></td>
    <td width="47%"><center>
      <B><FONT size=2 face="serif">88-0436055 </FONT></B>
    </center></td>
  </tr>
  <tr valign="top">
    <td><center>
      <B></B>      <FONT size=2 face="serif">(State or other jurisdiction or organization)</FONT>
    </center></td>
    <td><center>
    </center></td>
    <td>      <center>
      <FONT size=2 face="serif">(I.R.S. Employer Identification Number)</FONT>
    </center></td>
  </tr>
</table>
<P align="center"><B><FONT size=2 face="serif">VISUALMED CLINICAL SOLUTIONS CORP. <br>
1035 Laurier W. Suite 200 <br>
Montreal, Quebec <br>
Canada H2V 2L1 <br>
(514) 274-1115 <br>
</FONT></B><FONT size=2 face="serif">(Address and telephone of
executive offices, including zip code.)</FONT></P>
<P align="center">
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B><FONT size=2 face="serif">THE VISUALMED CLINICAL SOLUTIONS CORP. <br>
MARCH 2007 NONQUALIFIED STOCK OPTION PLAN</FONT></B><FONT size=2 face="serif"> </FONT></P>
<P align="center">
<B><FONT size=2 face="serif">Gerard Dab, Chairman &amp; CEO </FONT></B><BR>
<B><FONT size=2 face="serif">VISUALMED CLINICAL SOLUTIONS CORP.</FONT></B><BR>
<B><FONT size=2 face="serif">1035 Laurier W. Suite 200 </FONT></B><BR>
<B><FONT size=2 face="serif">Montreal, Quebec </FONT></B><BR>
<B><FONT size=2 face="serif">Canada H2V 2L1 </FONT></B><BR>
<B><FONT size=2 face="serif">(514) 274-1115 </FONT></B><BR>
<FONT size=2 face="serif">(Name, address and telephone of agent for service) </FONT></P>
<P align="center">
<FONT size=2 face="serif">Copies of all communications, including all communications sent to the agent for service, should be sent to:</FONT></P>
<P align="center">
<B><FONT size=2 face="serif">Stewart A. Merkin, Esq. </FONT></B><BR>
<B><FONT size=2 face="serif">Law Office of Stewart A. Merkin, P.A.</FONT></B><BR>
<B><FONT size=2 face="serif">Rivergate Plaza, Suite 300</FONT></B><FONT size=2 face="serif"> </FONT><BR>
<B><FONT size=2 face="serif">444 Brickell Avenue </FONT></B><BR>
<B><FONT size=2 face="serif">Miami, FL 33131 </FONT></B><BR>
<B><FONT size=2 face="serif">Tel. (305)357-5556 </FONT></B><BR>
<B><FONT size=2 face="serif">Fax (305)358-2490 </FONT></B></P>

<HR noshade align="center" width="100%" size=4>
<P align="left" style="page-break-before:always"></P><PAGE>


<TABLE width="100%" border=0 cellpadding=0 cellspacing=0>
<TR valign="bottom">
  <TD align=center colspan=11>
<B><FONT size=2 face="serif">CALCULATION OF REGISTRATION FEE</FONT></B>
  </TD>
</TR>
<TR>
  <TD colspan=11>&nbsp;

  </TD>
</TR>
<TR valign="bottom">
  <TD width="36%" align=left nowrap>

    <center>
    </center></TD>
  <TD width="8%" align=left nowrap>

    <center>
    </center></TD>
  <TD width="7%">
    <center>
    </center></TD>
  <TD colspan="2" align=left nowrap>

    <center>
    </center>

    <center>
    </center>

    <center>
    </center></TD>
  <TD width="10%">
    <center>
    </center></TD>
  <TD colspan="2" align=left nowrap>

    <center>
    </center>
    <center>
        <B><FONT size=1 face="serif">Proposed</FONT></B>
      </center></TD>
  <TD width="7%">
    <center>
    </center></TD>
  <TD colspan="2" align=left nowrap>

    <center>
    </center>

    <center>
    </center></TD>
  </TR>
<TR valign="bottom">
  <TD align=center nowrap>
    <center>
      <B><FONT size=1 face="serif">Title of Each Class of</FONT></B>
    </center></TD>
  <TD align=left nowrap>

    <center>
    </center></TD>
  <TD>
    <center>
    </center></TD>
  <TD align=left nowrap colspan=2>
    <center>
      <B><FONT size=1 face="serif">Aggregate Proposed</FONT></B>
    </center>

    <center>
    </center></TD>
  <TD>
    <center>
    </center></TD>
  <TD colspan="2" align=left nowrap>

    <center>
    </center>
    <center>
        <B><FONT size=1 face="serif">Maximum</FONT></B>
      </center></TD>
  <TD>
    <center>
    </center></TD>
  <TD colspan="2" align=left nowrap>

    <center>
    </center>
    <center>
        <B><FONT size=1 face="serif">Amount of</FONT></B>
      </center></TD>
  </TR>
<TR valign="bottom">
  <TD align=center nowrap>
    <center>
      <B><FONT size=1 face="serif">Securities to be</FONT></B>
    </center></TD>
  <TD align=right nowrap>
    <center>
      <B><FONT size=1 face="serif">Amount to be</FONT></B>
    </center></TD>
  <TD>
    <center>
    </center></TD>
  <TD align=center nowrap colspan=2>
    <center>
      <B><FONT size=1 face="serif">Maximum Offering</FONT></B>
    </center>

    <center>
    </center></TD>
  <TD>
    <center>
    </center></TD>
  <TD colspan="2" align=left nowrap>

    <center>
    </center>
    <center>
        <B><FONT size=1 face="serif">Aggregate Offering</FONT></B>
      </center></TD>
  <TD>
    <center>
    </center></TD>
  <TD colspan="2" align=left nowrap>

    <center>
    </center>
    <center>
        <B><FONT size=1 face="serif">Registration</FONT></B>
      </center></TD>
  </TR>
<TR valign="bottom">
  <TD align=center nowrap>
    <center>
      <B><FONT size=1 face="serif">Registered</FONT></B>
    </center></TD>
  <TD align=left nowrap>

    <center>
   <B><FONT size=1 face="serif">Registered</FONT></B>
  </center></TD>
  <TD>
    <center>
    </center></TD>
  <TD align=left nowrap colspan=2>
    <center>
      <B><FONT size=1 face="serif">Price per Unit/Share</FONT></B>
    </center>

    <center>
    </center></TD>
  <TD>
    <center>
    </center></TD>
  <TD colspan="2" align=left nowrap>

    <center>
    </center>
    <center>
        <B><FONT size=1 face="serif">Price [1]</FONT></B>
      </center></TD>
  <TD>
    <center>
    </center></TD>
  <TD colspan="2" align=left nowrap>

    <center>
    </center>
    <center>
        <B><FONT size=1 face="serif">Fee</FONT></B>
      </center></TD>
  </TR>
<TR>
  <TD colspan=11>&nbsp;

  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>
<FONT size=2 face="serif">Common Shares, &#36;0.00001 par value,</FONT>
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD>&nbsp;
  </TD>
  <TD width="2%" align=left nowrap>&nbsp;

  </TD>
  <TD width="10%" align=left nowrap>&nbsp;

  </TD>
  <TD>&nbsp;
  </TD>
  <TD width="2%" align=left nowrap>&nbsp;

  </TD>
  <TD width="10%" align=left nowrap>&nbsp;

  </TD>
  <TD>&nbsp;
  </TD>
  <TD width="1%" align=left nowrap>&nbsp;

  </TD>
  <TD width="7%" align=left nowrap>&nbsp;

  </TD>
</TR>
<TR valign="bottom">
  <TD align=center nowrap>
    <div align="left">&nbsp; &nbsp;<FONT size=2 face="serif">issuable upon exercise
        of stock options</FONT>
    </div></TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>
 &nbsp; &nbsp;<FONT size=2 face="serif">by Grantees</FONT>
  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">2,000,000</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">0.95</FONT>
<FONT size=2 face="serif">[1]</FONT></TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">1,900,000</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">58.33</FONT>
  </TD>
</TR>
<TR>
  <TD colspan=11>&nbsp;

  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>
<FONT size=2 face="serif">Totals</FONT>
  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">2,000,000</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">0.95</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">1,900,000</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">58.33</FONT>
  </TD>
</TR>
</TABLE>
<BR>
<P align="left">&nbsp;</P>
<table width="100%"  border="0" cellspacing="0" cellpadding="0">
  <tr>
    <td width="8%">&nbsp;</td>
    <td width="92%" colspan="2"><FONT size=2 face="serif">[1] Estimated solely for the purpose of calculating
        the registration fee pursuant to paragraphs (c) and (h) of Rule 457 under
        the Securities Act, as amended, based upon the average of the closing
        bid and ask prices for common shares, as quoted by the OTC Bulletin Board
    on March 19, 2007. </FONT></td>
  </tr>
</table>
<P align="left"><FONT size=2 face="serif">In addition, pursuant to rule 416(c)
    under the Securities Act of 1933 (the &#147;Act&#148;), this registration
    statement also covers an indeterminate amount of interests to be offered
or sold pursuant to the employee benefit plan described herein. </FONT></P>
<BR>
<HR noshade align="center" width="100%" size=4>
<P align="left" style="page-break-before:always"></P><PAGE>

<P align="left">
<B><FONT size=2 face="serif">PART I. INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS. </FONT></B><FONT size=2 face="serif"> </FONT></P>
<P align="left">
<B><FONT size=2 face="serif">ITEM 1. PLAN INFORMATION</FONT></B><BR>
<BR>
<FONT size=2 face="serif">See Item 2 below.</FONT></P>
<P align="left">
<B><FONT size=2 face="serif">ITEM 2. REGISTRANT INFORMATION AND EMPLOYEE PLAN ANNUAL INFORMATION. </FONT></B><FONT size=2 face="serif"> </FONT></P>
<P align="left">
<FONT size=2 face="serif">The document containing the information specified in Part I of this registration statement on Form S-8 will be sent or given to participants in the Plan as specified by Rule 428(b)(1) under the Act, as amended. Such
documents are not required to be, and are not being, filed by the Registrant with the Securities and Exchange Commission, either as part of this registration statement or as prospectuses or prospectus supplements pursuant to Rule 424 under the Act,
as amended. Such documents, together with the documents incorporated by reference herein pursuant to Item 3 of Part II of this registration statement on Form S-8, constitute a prospectus that meets the requirements of Section 10(a) of the Act, as
amended.</FONT></P>
<P align="left">
<FONT size=2 face="serif">The documents incorporated by reference in Item 3 of Part II of this registration statement are incorporated by reference in the Section 10(a) prospectus, and are available without charge, upon written or oral request to
VisualMED Clinical Solutions Corp., 1035 Laurier W., Suite 200, Montreal, Quebec Canada, H2V 2L1, (514) 274-1115, Attention: Corporate Secretary.</FONT></P>
<P align="left">
<B><FONT size=2 face="serif">PART II. INFORMATION REQUIRED IN THE REGISTRATION STATEMENT. </FONT></B><FONT size=2 face="serif"> </FONT></P>
<P align="left">
<B><FONT size=2 face="serif">ITEM 3. INCORPORATION OF DOCUMENTS BY REFERENCE. </FONT></B><FONT size=2 face="serif"> </FONT></P>
<P align="left">
<FONT size=2 face="serif">The Registrant hereby incorporates by reference into this Registration Statement the documents listed below. In addition, all documents subsequently filed pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Securities
Exchange Act of 1934 (the "Exchange Act"), prior to the filing of a post-effective amendment which indicates that all securities offered have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by
reference into this Registration Statement and to be a part hereof from the date of filing of such documents: </FONT></P>
<TABLE width="100%" border=0 cellpadding=0 cellspacing=0>
<TR>
  <TD width="8%" valign=top nowrap>&nbsp;</TD>
  <TD width="5%" valign=top nowrap>
<FONT size=2 face="serif">(a)</FONT>&nbsp; &nbsp; &nbsp;   </TD>
  <TD width="91%">
<FONT size=2 face="serif">The Registrant&#146;s Annual Report on Form 10-KSB for the fiscal year ended June 30, 2006; and</FONT>  </TD>
</TR>
<TR><TD colspan=3>&nbsp;</TD></TR><TR>
  <TD width="8%" valign=top nowrap>&nbsp;</TD>
  <TD nowrap valign=top>
<FONT size=2 face="serif">(b)</FONT>&nbsp; &nbsp; &nbsp;   </TD>
  <TD>
<FONT size=2 face="serif">All other reports filed pursuant to section 13(a) or 15(d) of the Securities Exchange Act of 1934, since the end of the fiscal year covered by the Registrant&#146;s document referred to in (a) above.</FONT>  </TD>
</TR>
</TABLE>
<P align="left">
<FONT size=2 face="serif">&nbsp; </FONT></P>
<P align="left">

<HR noshade align="center" width="100%" size=4>


<P align="left" style="page-break-before:always"></P><PAGE>
<B><FONT size=2 face="serif">ITEM 4. DESCRIPTION OF SECURITIES. </FONT></B><FONT size=2 face="serif"> </FONT></P>



<P align="left">
<B><FONT size=2 face="serif">Common Stock</FONT></B></P>
<P align="left">
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Our authorized capital stock consists of 100,000,000 shares of common stock, &#36;0.00001 par value per share. The holders of our common stock:</FONT></P>
<UL>
<LI>
<FONT size=2 face="serif">have equal ratable rights to dividends from funds legally available if and when declared by our</FONT> <FONT size=2 face="serif">board of directors;</FONT></LI>
<LI>
<FONT size=2 face="serif">are entitled to share ratably in all of our assets available for distribution to holders of common</FONT> <FONT size=2 face="serif">stock upon liquidation, dissolution or winding up of our affairs;</FONT></LI>
</UL>

<HR noshade align="center" width="100%" size=4>



<P align="left" style="page-break-before:always"></P><PAGE>


<UL>
<LI>
<FONT size=2 face="serif">do not have preemptive, subscription or conversion rights and there are no redemption or sinking</FONT> <FONT size=2 face="serif">fund provisions or rights; and</FONT></LI>
<LI>
<FONT size=2 face="serif">are entitled to one non-cumulative vote per share on all matters on which stockholders may vote.</FONT></LI>
</UL>
<P align="left">
<FONT size=2 face="serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As of March 19, 2007, we had 47,758,354 shares of common stock outstanding.</FONT></P>
<P align="left">
<B><FONT size=2 face="serif">Non-cumulative voting</FONT></B></P>
<P align="left">
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Holders of shares of our common stock do not have cumulative voting rights, which means that the holders of more than 50% of the outstanding shares, voting for the election of directors, can
elect all of the directors to be elected, if they so choose, and, in that event, the holders of the remaining shares will not be able to elect any of our directors. </FONT></P>
<P align="left">
<B><FONT size=2 face="serif">Cash dividends</FONT></B></P>
<P align="left">
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">We have not declared any cash dividends in the last two fiscal years. We intend to retain future earnings for use in our business and do not anticipate declaring or paying any cash or stock
dividends on shares of our common shares in the near future. In addition, any determination to declare and pay dividends will be made by our Board of Directors in light of our earnings, financial position, capital requirements and other factors that
our Board of Directors deems relevant. </FONT></P>
<P align="left">
<B><FONT size=2 face="serif">Warrants</FONT></B></P>
<P align="left">
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">As of March 19, 2007, there are 262,122 warrants outstanding to purchase common stock at an exercise price of &#36;1.25 per share. The warrants are immediately exercisable and these warrants
are exercisable for a period of twenty-four months after the date of issuance, after which they will expire if not exercised. See the section of this prospectus entitled &#147;Selling Stockholders&#148; and &#147;Recent Sales of Unregistered
Securities.&#148; </FONT></P>
<P align="left">
<B><FONT size=2 face="serif">Anti-takeover provisions</FONT></B></P>
<P align="left">
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">There are no Nevada anti-takeover provisions that may have the effect of delaying or preventing a change in control. </FONT></P>
<P align="left">
<B><FONT size=2 face="serif">Stock transfer agent</FONT></B></P>
<P align="left">
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Our stock transfer agent for our securities is Olde Monmouth Stock Transfer Co., Inc., 200 Memorial Parkway, Atlantic Highlands, NJ 07716 and its telephone number is (732) 872-2727. </FONT></P>
<P align="left">
<B><FONT size=2 face="serif">ITEM 5. INTEREST OF NAMED EXPERTS AND COUNSEL.</FONT></B><FONT size=2 face="serif"> </FONT></P>
<P align="left">
<FONT size=2 face="serif">Not Applicable.</FONT></P>
<P align="left">

<HR noshade align="center" width="100%" size=4>



<P align="left" style="page-break-before:always"></P>
<PAGE>

<B><FONT size=2 face="serif">ITEM 6. INDEMNIFICATION OF DIRECTORS AND OFFICERS.</FONT></B></P>
<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Under our articles of incorporation and bylaws, we may indemnify an officer or director who is made a party to any proceeding, including a lawsuit, because of his position, if he acted in good
  faith and in a manner he reasonably believed to be in our best interest. We may advance expenses incurred in defending a proceeding. To the extent that the officer or director is successful on the merits in a proceeding as to which he is to be
  indemnified, we must indemnify him against all expenses incurred, including attorney&#146;s fees. With respect to a derivative action, indemnity may be made only for expenses actually and reasonably incurred in defending the proceeding, and if the
  officer or director is judged liable, only by a court order. The indemnification is intended to be to the fullest extent permitted by the laws of the State of Nevada.</FONT></P>
<P align="left">
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Insofar as indemnification for liabilities arising under the Act may be permitted to directors, officers and controlling persons of the small business issuer pursuant to the foregoing
provisions, or otherwise, the small business issuer has been advised that in the opinion of the Securities Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. </FONT></P>
<P align="left">
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Regarding indemnification for liabilities arising under the Act, which may be permitted to directors or officers under Nevada law, we are informed that, in the opinion of the Securities and
Exchange Commission, indemnification is against public policy, as expressed in the Act and is, therefore, unenforceable.</FONT></P>
<P align="left">
<B><FONT size=2 face="serif">ITEM 7. EXEMPTION FROM REGISTRATION.</FONT></B></P>
<P align="left">
<FONT size=2 face="serif">Not Applicable.</FONT><BR>
<BR>
<B><FONT size=2 face="serif">ITEM 8. EXHIBITS.</FONT></B></P>
<TABLE width="100%" border=0 cellpadding=0 cellspacing=0>
<TR valign="bottom">
  <TD align=left nowrap>
<FONT size=2 face="serif">Exhibit 4.1</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">VisualMED Clinical Solutions Corp. March 2007 Nonqualified Stock Option Plan</FONT>
  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>
<FONT size=2 face="serif">Exhibit 4.2</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">Form of Non-Qualified Stock Option Agreement</FONT>
  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>
<FONT size=2 face="serif">Exhibit 5.1</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">Opinion of Stewart A. Merkin, Esq., Attorney at Law</FONT>
  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>
<FONT size=2 face="serif">Exhibit 23.1</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">Consent of Stewart A. Merkin, Esq., (included in Exhibit 5.1)</FONT>
  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>
<FONT size=2 face="serif">Exhibit 23.2</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">Consent of Manning Elliott LLP, Independent Registered Public Accounting Firm</FONT>
  </TD>
</TR>
</TABLE>
<BR>
<P align="left">
<B><FONT size=2 face="serif">ITEM 9. UNDERTAKINGS.</FONT></B><FONT size=2 face="serif"> </FONT><BR>
<BR>
<FONT size=2 face="serif">The undersigned registrant hereby undertakes:</FONT></P>
<P align="left">
<FONT size=2 face="serif">1. To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement; </FONT></P>
<P align="left"><FONT size=2 face="serif">2. To include any material information
    with respect to the plan of distribution not previously disclosed in the
    registration statement or any material change to such information in the
    registration statement; </FONT></P>
<HR noshade align="center" width="100%" size=4>



<P align="left" style="page-break-before:always"></P><PAGE>


<P align="left">
<FONT size=2 face="serif">3. That, for the purpose of determining any liability under the Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such
securities at that time shall be deemed to be the initial bona fide offering thereof; and </FONT></P>
<P align="left"><FONT size=2 face="serif">4. To remove from registration by means
    of a post-effective amendment any of the securities being registered which
    remain unsold at the termination of the offering.</FONT></P>
<P align="left">
<FONT size=2 face="serif">The undersigned registrant hereby undertakes that, for the purposes of determining any liability under the Act, each filing of the Registrant&#146;s annual report pursuant to Section 13(a) or Section 15(d) of the Securities
Exchange Act of 1934 that is incorporated by reference in the registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
</FONT></P>

<HR noshade align="center" width="100%" size=4>



<P align="left" style="page-break-before:always"></P><PAGE>


<P align="center">
<B><FONT size=2 face="serif">SIGNATURES</FONT></B></P>
<P align="left">
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and
has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Montreal, Quebec, Canada on March 19, 2007. </FONT></P>
<P align="center">
<FONT size=2 face="serif">VISUALMED CLINICAL SYSTEMS CORP.</FONT></P>
<P align="left">
<P style="MARGIN-LEFT: 50%" align=left><FONT size=2 face="serif">By: /s/Gerard Dab </FONT><BR>
<FONT size=2 face="serif">Gerard Dab, </FONT><BR>
<FONT size=2 face="serif">Principal Executive Officer</FONT></P>
</p><P align="left">
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT size=2 face="serif">Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated. </FONT></P>
<TABLE width="100%" border=0 cellpadding=0 cellspacing=0>
<TR valign="bottom">
  <TD align=left nowrap>
<B><FONT size=1 face="serif">Signature</FONT></B>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>
<B><FONT size=1 face="serif">Title</FONT></B>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>
<B><FONT size=1 face="serif">Date</FONT></B>
  </TD>
</TR>
<TR>
  <TD colspan=5>&nbsp;

  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">Principle Executive Officer, Secretary</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">March 19, 2007</FONT>
  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">/s/ Gerard Dab</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">and a member of the Board of Directors</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>
<FONT size=2 face="serif">Gerard Dab</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
</TR>
<TR>
  <TD colspan=5>&nbsp;

  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">President, Chief Science Officer and a</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">March 19, 2007</FONT>
  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">/s/ Arthur Gelston MD</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">member of the Board of Directors</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>
<FONT size=2 face="serif">Arthur Gelston MD</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
</TR>
<TR>
  <TD colspan=5>&nbsp;

  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">Principal Financial Officer, Principal</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">March 19, 2007</FONT>
  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">/s/ Larry Kurlender</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">Accounting Officer and Treasurer</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>
<FONT size=2 face="serif">Larry Kurlender</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
</TR>
<TR>
  <TD colspan=5>&nbsp;

  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">/s/ Louis J. Lombardo</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">A member of the Board of Directors</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">March 19, 2007</FONT>
  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>
<FONT size=2 face="serif">Louis J. Lombardo</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
</TR>
<TR>
  <TD colspan=5>&nbsp;

  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">/s/ Philippe Panzini</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">A member of the Board of Directors</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">March 19, 2007</FONT>
  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>
<FONT size=2 face="serif">Philippe Panzini</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
</TR>
</TABLE><BR>

<HR noshade align="center" width="100%" size=4>






</BODY>

</HTML>
[{"type": "S-8", "sequence": "1", "filename": "c47561_s8.htm", "secsgml_size_bytes": 29918}]
{"company-data": {"conformed-name": "VisualMED Clinical Solutions Corp.", "cik": "0001102942", "assigned-sic": "7373", "irs-number": "880436055", "state-of-incorporation": "NV", "fiscal-year-end": "0630"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-141515", "film-number": "07712459"}, "business-address": {"street1": "1035 LAURIER STREET WEST", "city": "MONTREAL", "state": "A8", "zip": "H2V 2L1", "phone": "(514) 274-1115"}, "mail-address": {"street1": "1035 LAURIER STREET WEST", "city": "MONTREAL", "state": "A8", "zip": "H2V 2L1"}, "former-company": [{"former-conformed-name": "VisualMED Clinical Systems Corp.", "date-changed": "20050106"}, {"former-conformed-name": "ANCONA MINING CORP", "date-changed": "20000111"}]}
c47561_s8.htm -- Converted by SEC Publisher, created by BCL Technologies Inc., for SEC Filing
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
Registration Statement
Under
The Securities Act of 1933, as
amended.
VISUALMED CLINICAL SOLUTIONS CORP.
(Exact
name of registrant as specified in charter.)
Nevada
88-0436055
(State or other jurisdiction or organization)
(I.R.S. Employer Identification Number)
VISUALMED CLINICAL SOLUTIONS CORP.
1035 Laurier W. Suite 200
Montreal, Quebec
Canada H2V 2L1
(514) 274-1115
(Address and telephone of
executive offices, including zip code.)
THE VISUALMED CLINICAL SOLUTIONS CORP.
MARCH 2007 NONQUALIFIED STOCK OPTION PLAN
Gerard Dab, Chairman & CEO
VISUALMED CLINICAL SOLUTIONS CORP.
1035 Laurier W. Suite 200
Montreal, Quebec
Canada H2V 2L1
(514) 274-1115
(Name, address and telephone of agent for service)
Copies of all communications, including all communications sent to the agent for service, should be sent to:
Stewart A. Merkin, Esq.
Law Office of Stewart A. Merkin, P.A.
Rivergate Plaza, Suite 300
444 Brickell Avenue
Miami, FL 33131
Tel. (305)357-5556
Fax (305)358-2490
CALCULATION OF REGISTRATION FEE
Proposed
Title of Each Class of
Aggregate Proposed
Maximum
Amount of
Securities to be
Amount to be
Maximum Offering
Aggregate Offering
Registration
Registered
Registered
Price per Unit/Share
Price [1]
Fee
Common Shares, $0.00001 par value,
issuable upon exercise
        of stock options
by Grantees
2,000,000
$
0.95
[1]
$
1,900,000
$
58.33
Totals
2,000,000
$
0.95
$
1,900,000
$
58.33
[1] Estimated solely for the purpose of calculating
        the registration fee pursuant to paragraphs (c) and (h) of Rule 457 under
        the Securities Act, as amended, based upon the average of the closing
        bid and ask prices for common shares, as quoted by the OTC Bulletin Board
    on March 19, 2007.
In addition, pursuant to rule 416(c)
    under the Securities Act of 1933 (the "Act"), this registration
    statement also covers an indeterminate amount of interests to be offered
or sold pursuant to the employee benefit plan described herein.
PART I. INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS.
ITEM 1. PLAN INFORMATION
See Item 2 below.
ITEM 2. REGISTRANT INFORMATION AND EMPLOYEE PLAN ANNUAL INFORMATION.
The document containing the information specified in Part I of this registration statement on Form S-8 will be sent or given to participants in the Plan as specified by Rule 428(b)(1) under the Act, as amended. Such
documents are not required to be, and are not being, filed by the Registrant with the Securities and Exchange Commission, either as part of this registration statement or as prospectuses or prospectus supplements pursuant to Rule 424 under the Act,
as amended. Such documents, together with the documents incorporated by reference herein pursuant to Item 3 of Part II of this registration statement on Form S-8, constitute a prospectus that meets the requirements of Section 10(a) of the Act, as
amended.
The documents incorporated by reference in Item 3 of Part II of this registration statement are incorporated by reference in the Section 10(a) prospectus, and are available without charge, upon written or oral request to
VisualMED Clinical Solutions Corp., 1035 Laurier W., Suite 200, Montreal, Quebec Canada, H2V 2L1, (514) 274-1115, Attention: Corporate Secretary.
PART II. INFORMATION REQUIRED IN THE REGISTRATION STATEMENT.
ITEM 3. INCORPORATION OF DOCUMENTS BY REFERENCE.
The Registrant hereby incorporates by reference into this Registration Statement the documents listed below. In addition, all documents subsequently filed pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Securities
Exchange Act of 1934 (the "Exchange Act"), prior to the filing of a post-effective amendment which indicates that all securities offered have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by
reference into this Registration Statement and to be a part hereof from the date of filing of such documents:
(a)
The Registrant's Annual Report on Form 10-KSB for the fiscal year ended June 30, 2006; and
(b)
All other reports filed pursuant to section 13(a) or 15(d) of the Securities Exchange Act of 1934, since the end of the fiscal year covered by the Registrant's document referred to in (a) above.
ITEM 4. DESCRIPTION OF SECURITIES.
Common Stock
Our authorized capital stock consists of 100,000,000 shares of common stock, $0.00001 par value per share. The holders of our common stock:
have equal ratable rights to dividends from funds legally available if and when declared by our
board of directors;
are entitled to share ratably in all of our assets available for distribution to holders of common
stock upon liquidation, dissolution or winding up of our affairs;
do not have preemptive, subscription or conversion rights and there are no redemption or sinking
fund provisions or rights; and
are entitled to one non-cumulative vote per share on all matters on which stockholders may vote.
As of March 19, 2007, we had 47,758,354 shares of common stock outstanding.
Non-cumulative voting
Holders of shares of our common stock do not have cumulative voting rights, which means that the holders of more than 50% of the outstanding shares, voting for the election of directors, can
elect all of the directors to be elected, if they so choose, and, in that event, the holders of the remaining shares will not be able to elect any of our directors.
Cash dividends
We have not declared any cash dividends in the last two fiscal years. We intend to retain future earnings for use in our business and do not anticipate declaring or paying any cash or stock
dividends on shares of our common shares in the near future. In addition, any determination to declare and pay dividends will be made by our Board of Directors in light of our earnings, financial position, capital requirements and other factors that
our Board of Directors deems relevant.
Warrants
As of March 19, 2007, there are 262,122 warrants outstanding to purchase common stock at an exercise price of $1.25 per share. The warrants are immediately exercisable and these warrants
are exercisable for a period of twenty-four months after the date of issuance, after which they will expire if not exercised. See the section of this prospectus entitled "Selling Stockholders" and "Recent Sales of Unregistered
Securities."
Anti-takeover provisions
There are no Nevada anti-takeover provisions that may have the effect of delaying or preventing a change in control.
Stock transfer agent
Our stock transfer agent for our securities is Olde Monmouth Stock Transfer Co., Inc., 200 Memorial Parkway, Atlantic Highlands, NJ 07716 and its telephone number is (732) 872-2727.
ITEM 5. INTEREST OF NAMED EXPERTS AND COUNSEL.
Not Applicable.
ITEM 6. INDEMNIFICATION OF DIRECTORS AND OFFICERS.
Under our articles of incorporation and bylaws, we may indemnify an officer or director who is made a party to any proceeding, including a lawsuit, because of his position, if he acted in good
  faith and in a manner he reasonably believed to be in our best interest. We may advance expenses incurred in defending a proceeding. To the extent that the officer or director is successful on the merits in a proceeding as to which he is to be
  indemnified, we must indemnify him against all expenses incurred, including attorney's fees. With respect to a derivative action, indemnity may be made only for expenses actually and reasonably incurred in defending the proceeding, and if the
  officer or director is judged liable, only by a court order. The indemnification is intended to be to the fullest extent permitted by the laws of the State of Nevada.
Insofar as indemnification for liabilities arising under the Act may be permitted to directors, officers and controlling persons of the small business issuer pursuant to the foregoing
provisions, or otherwise, the small business issuer has been advised that in the opinion of the Securities Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable.
Regarding indemnification for liabilities arising under the Act, which may be permitted to directors or officers under Nevada law, we are informed that, in the opinion of the Securities and
Exchange Commission, indemnification is against public policy, as expressed in the Act and is, therefore, unenforceable.
ITEM 7. EXEMPTION FROM REGISTRATION.
Not Applicable.
ITEM 8. EXHIBITS.
Exhibit 4.1
VisualMED Clinical Solutions Corp. March 2007 Nonqualified Stock Option Plan
Exhibit 4.2
Form of Non-Qualified Stock Option Agreement
Exhibit 5.1
Opinion of Stewart A. Merkin, Esq., Attorney at Law
Exhibit 23.1
Consent of Stewart A. Merkin, Esq., (included in Exhibit 5.1)
Exhibit 23.2
Consent of Manning Elliott LLP, Independent Registered Public Accounting Firm
ITEM 9. UNDERTAKINGS.
The undersigned registrant hereby undertakes:
1. To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement;
2. To include any material information
    with respect to the plan of distribution not previously disclosed in the
    registration statement or any material change to such information in the
    registration statement;
3. That, for the purpose of determining any liability under the Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such
securities at that time shall be deemed to be the initial bona fide offering thereof; and
4. To remove from registration by means
    of a post-effective amendment any of the securities being registered which
    remain unsold at the termination of the offering.
The undersigned registrant hereby undertakes that, for the purposes of determining any liability under the Act, each filing of the Registrant's annual report pursuant to Section 13(a) or Section 15(d) of the Securities
Exchange Act of 1934 that is incorporated by reference in the registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and
has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Montreal, Quebec, Canada on March 19, 2007.
VISUALMED CLINICAL SYSTEMS CORP.
By: /s/Gerard Dab
Gerard Dab,
Principal Executive Officer
Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.
Signature
Title
Date
Principle Executive Officer, Secretary
March 19, 2007
/s/ Gerard Dab
and a member of the Board of Directors
Gerard Dab
President, Chief Science Officer and a
March 19, 2007
/s/ Arthur Gelston MD
member of the Board of Directors
Arthur Gelston MD
Principal Financial Officer, Principal
March 19, 2007
/s/ Larry Kurlender
Accounting Officer and Treasurer
Larry Kurlender
/s/ Louis J. Lombardo
A member of the Board of Directors
March 19, 2007
Louis J. Lombardo
/s/ Philippe Panzini
A member of the Board of Directors
March 19, 2007
Philippe Panzini